Merck & Co., Inc. (MRK) Yield on Cost (YOC): 2.80%
The yield on cost (YOC) for Merck & Co., Inc. (MRK) is 2.80%.
MRK Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
2.80%
Forward Yield on Cost Projections
If you buy MRK today at the current stock price of $118.47 with a yield of 2.80% and dividends continue to grow at the historical rate (6.8% CAGR), your YOC would be:
Current Yield
2.80%
YOC in 3 Years
3.52%
YOC in 5 Years
4.10%
YOC in 10 Years
6.00%
Interactive Yield on Cost Calculator
Project custom investment returns for Merck & Co., Inc. (MRK) based on your custom cost basis.
Starting Yield
2.80%
Ending YOC
7.47%
Year 15 Dividend
$8.84
Cum. Dividends Recd.
$87.36
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $3.32 | — | 2.80% | $0.00 |
| Year 1 | $3.54 | +6.75% | 2.99% | $3.54 |
| Year 2 | $3.78 | +6.75% | 3.19% | $7.33 |
| Year 3 | $4.04 | +6.75% | 3.41% | $11.37 |
| Year 4 | $4.31 | +6.75% | 3.64% | $15.68 |
| Year 5 | $4.60 | +6.75% | 3.88% | $20.28 |
| Year 6 | $4.91 | +6.75% | 4.15% | $25.19 |
| Year 7 | $5.24 | +6.75% | 4.43% | $30.44 |
| Year 8 | $5.60 | +6.75% | 4.73% | $36.04 |
| Year 9 | $5.98 | +6.75% | 5.04% | $42.01 |
| Year 10 | $6.38 | +6.75% | 5.39% | $48.39 |
| Year 11 | $6.81 | +6.75% | 5.75% | $55.20 |
| Year 12 | $7.27 | +6.75% | 6.14% | $62.47 |
| Year 13 | $7.76 | +6.75% | 6.55% | $70.23 |
| Year 14 | $8.28 | +6.75% | 6.99% | $78.52 |
| Year 15 | $8.84 | +6.75% | 7.47% | $87.36 |
Yield on Cost (YOC) Formula
Formula: Yield on Cost = Annual Dividend / Original Purchase Price × 100
Inputs shown in the projection:
- Original purchase price.
- Annual dividend per share at the starting point.
- Assumed annual dividend growth rate.
- Projected annual dividend divided by original purchase price.
Note: Forward projections assume dividends continue to grow at the designated growth rate. Actual dividend payments are declared by corporate boards and are subject to change.
Merck & Co., Inc. Yield on Cost (YOC) Formula & Definition
Yield on Cost shows the dividend yield based on your original purchase price. As dividends grow, your YOC increases even if the market yield stays the same.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Merck & Co., Inc. Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Merck & Co., Inc. (MRK)?
- The yield on cost (YOC) for MRK stock is 2.80%.
About Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert Davis